Patent Number: 8,715,694

Title: Recombinant dengue virus antigen comprising the capsid protein leader sequence, full-length prM protein, and full-length E protein

Abstract: The invention provides polypeptides and virus-like particles having, for example, an ability to induce an immune response to flaviviruses. The polypeptides can include C15, prM, and E polypeptide sequences.

Inventors: Apt; Doris (San Jose, CA), Punnonen; Juha (Belmont, CA), Brinkman; Alice M. (Tustin, CA)

Assignee: Altravax, Inc.

International Classification: A61K 39/12 (20060101); A61K 39/00 (20060101)

Expiration Date: 5/06/12018